NCT03162549
CorEvitas Inflammatory Bowel Disease (IBD) Registry
Enrolling by Invitation
Not specifiedAges 18+ObservationalCorEvitasGovernment-funded
~2,287 participants
Updated 2025-10-02 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
IBD epidemiology, presentation, natural history, management, and outcomes
Measured over Time Frame: A minimum of 10 years from last patient enrolled
Conditions
Where it's being run
1 sites across 1 statesMassachusetts1
Study leadership
- Jeffrey Greenberg, MD · STUDY_DIRECTOR · CorEvitas, LLC
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
At least 18 years of age or older.
Willing and able to provide written consent for participation in the IBD Registry.
Willing and able to provide Personally Identifiable Information (PII) which includes the following types of personal information at a minimum: full name, date of birth, sex, and home address zip code.
Diagnosis of one of the following by a gastroenterologist:
Prevalent users or new /incident users of an approved biologic drug or JAK inhibitor (Tofacitinib) for the treatment of UC or Crohn's disease.
What this trial measures
- IBD epidemiology, presentation, natural history, management, and outcomesTime Frame: A minimum of 10 years from last patient enrolled
The major clinical outcomes include an assessment of the epidemiology of Inflammatory Bowel Disease; to better understand the presentation, natural history, management and outcomes.